Mesenchymal stem cell-derived conditioned medium demonstrates antifungal activity against ocular isolates of Candida albicans and Aspergillus flavus: a proof-of-concept study.
Abbireddy S., Joseph J., Bagga B., Shukla S.
Laboratory Study on Face & Skin, published in Exp Eye Res (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Exp Eye Res (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42521071
- DOI
- 10.1016/j.exer.2026.111185
Abstract (original English)
Ocular fungal infections are potentially sight threatening and their treatment is challenged by increasing burden of antifungal resistance. This study, in search of novel therapeutic strategies, aims to evaluate the antifungal efficacy of mesenchymal stem cell-derived conditioned medium (MSC-CM) derived from human adipose tissue (AD), bone marrow (BM), dental pulp (DP), and umbilical cord (UC) sources against ocular clinical isolates of Candida albicans and Aspergillus flavus. The effect of MSC-CM on fungal growth was evaluated by colony-forming unit assay, whereas morphological alterations were assessed using scanning electron microscopy (SEM). MSC-CM from all four tissue sources significantly inhibited the growth of C. albicans and A. flavus. Compared with control, AD-MSC-CM showed comparatively greater reduction across both the ATCC (36.17 × 10 9 CFU/mL vs 1.52 × 10 9 CFU/mL)) and ocular clinical strains (51.30 × 10 10 CFU/mL vs 1.07 × 10 10 CFU/mL) of C. albicans whereas DP-MSC-CM demonstrated the highest inhibition for A. flavus (ATCC: 17.14 × 10 10 CFU/mL vs 2.003 × 10 10 CFU/mL, and Clinical: 4.91 × 10 12 CFU/mL vs 0.710 × 10 12 CFU/mL). SEM imaging confirmed morphological damage, including surface irregularities, invaginations, and cell wall deformations in MSC-CM-treated fungi. These findings, for the first time, present a proof-of-concept that MSC-CM may serve as a pr
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Oncologic safety of autologous fat grafting in head and neck cancer patients: A scoping review.
Systematic Review with a reported sample of 116 on Face & Skin, published in Med Oral Patol Oral Cir Bucal (2026) — summary generated from the PubMed abstract.
- 2026
- n = 116
Med Oral Patol Oral Cir Bucal - Level ASystematic ReviewEurope PMC
Stem cell-derived exosomes in tissue regeneration of oral and maxillofacial region: A systematic review
Systematic Review on Chronic Wound, published in Medicine (Baltimore) (2026) — summary generated from the PubMed abstract.
- 2026
Medicine (Baltimore) - Level AMeta-analysisPubMed
Stromal Vascular Fraction-Assisted Fat Grafting: A Systematic Review and Meta-analysis of Clinical Outcomes.
Meta-analysis on Face & Skin, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
- 2026
Aesthetic Plast Surg - Level ASystematic ReviewEurope PMC
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives
Systematic Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci2 citations - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Osteogenic and Biocompatibility Potential of Polylactic Acid-Based Materials: A Systematic Review of Human Primary Cells Studies
Systematic Review on Face & Skin, published in J Funct Biomater (2026) — summary generated from the PubMed abstract.
- 2026
J Funct Biomater